Study of the Reduction of the Prescriptions of Benzodiazepines and Related

Study of the Reduction of the Prescriptions of Benzodiazepines and Related After the Discharge of a Service of Follow-up Care and Geriatric Rehabilitation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06107283

Acronym

BZD

Enrollment

150

Registered

2023-10-30

Start date

2023-03-01

Completion date

2024-08-17

Last updated

2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression in Old Age

Keywords

Depression in Old Age, Benzodiazepines drugs, Geriatrics

Brief summary

The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subject of numerous studies, leading to falls, addictions and even deaths. The general practitioner is often faced with long-term medication intake which is not consistent with a good benefit/risk balance, but stopping or reducing the dosage remains a problem in current practice. The Aftercare and Geriatric Rehabilitation services due to their operation (several weeks of hospitalization) seek to adapt the patient's therapies in order to obtain the most convincing benefit/risk balance possible. A reduction or withdrawal of treatments with Benzodiazepines or related drugs are therefore frequently initiated.

Detailed description

The aim of this research is to quantify among the patients who benefited from a dosage reduction of Benzodiazepines and related drugs during a stay in the Geriatric Care and Aftercare and Rehabilitation department, the number of patients who had an increase of this treatment within 12 weeks following discharge from hospitalization.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

75 Years to No maximum

Healthy volunteers

Inclusion criteria

* Major subject (≥ 75 years old) * Subject discharged from a geriatric Follow-up Care and Rehabilitation service for whom a reduction in the dosage of Benzodiazepines and related drugs was carried out during hospitalization and who returned home (individual or EHPAD) after hospitalization. * Subject not opposing, after information, the reuse of their data for the purposes of this research.

Exclusion criteria

* Subject having expressed opposition to participating in the study. * Subject having treatment with Benzodiazepine to prevent recurrence of epileptic seizures.

Design outcomes

Primary

Measure	Time frame
The number of patients who had an increase in Benzodiazepines in the 12 weeks following discharge from hospitalization.	12 weeks following discharge from hospitalization.

Countries

France

Outcome results